Cannabis Report
Home > Boards > US OTC > Cannabis >

MGC Pharmaceuticals (MGCLF)

MGCLF RSS Feed
Add MGCLF Price Alert      Hide Sticky   Hide Intro
Moderator: rushmann
Search This Board: 
Last Post: 9/24/2018 1:11:05 PM - Followers: 20 - Board type: Free - Posts Today: 2

MGC Pharmaceutical
Web https://mgcpharma.com.au/

2018 INVESTOR PRESENTATION - A MUST READ
https://www.asx.com.au/asxpdf/20180515/pdf/43v17fngw661gw.pdf


3 DIVISIONS, MGC DERMA, MGC PHARMA, MGC BOTANIC
 
    Our three pioneering divisions allow MGC to be a key player in all significant levels of production in various global locations. It also allows MGC to progress with simultaneous high level research and development, clinical trials around the world and to embrace new emerging verticals in CBD markets.
 
ASX ANNOUNCEMENTS

MAY 2018 INVESTOR PRESENTATION      https://www.asx.com.au/asxpdf/20180515/pdf/43v17fngw661gw.pdf
MGC Gets Malta Deal 4/11/2018.                    https://www.asx.com.au/asxpdf/20180411/pdf/43t3r4swx14w98.pdf
 MGC LAUCHES NUTRACUTICAL LINE                                   https://www.asx.com.au/asxpdf/20180313/pdf/43scvsghl1fc2d.pdf
  MGC OPERATIONAL AND STRATEGY UPDATE                                  https://www.asx.com.au/asxpdf/20180305/pdf/43s586l6nvkppc.pdf
MGC HALF YEAR REPORT                                                     https://www.asx.com.au/asxpdf/20180226/pdf/43rx51n042y5dl.pdf
MGC LAUCHES ON CULT BEAUTY                                      https://www.asx.com.au/asxpdf/20180214/pdf/43rkmpx96lpj7d.pdf
MGC DECEMBER QUARTERLY REPORT                             https://www.asx.com.au/asxpdf/20180131/pdf/43r7dl2c3cv8lc.pdf
MGC INITIAL GMP CERTIFICATION                                   https://www.asx.com.au/asxpdf/20180125/pdf/43r1dqgtgcyhtx.pdf  
MGC LAUCHES PSORIASIS CREAM                                       https://www.asx.com.au/asxpdf/20180104/pdf/43qm6s1tzwb5pw.pdf
PURCHASE ORDER OF $40MIL VC DEAL REC'D                                   https://www.asx.com.au/asxpdf/20171114/pdf/43p6pqsf5jtgcc.pdf
MGC DERMA $40MIL DEAL EXECUTED                             https://www.asx.com.au/asxpdf/20171114/pdf/43p6pqsf5jtgcc.pdf
MGC BOTANICAL DIVISION UPDATE                                 https://www.asx.com.au/asxpdf/20171013/pdf/43n67fw0jy5j5l.pdf
MAJOR EUROPEAN PHARMA DEAL SIGNED                      https://www.asx.com.au/asxpdf/20171003/pdf/43mwyt2nty4zr4.pdf
MULTI MILLION AUSTRALIAN PHARMA DEAL                    https://www.asx.com.au/asxpdf/20171101/pdf/43nvx92qtdfjzm.pdf

Founded in 2014 by experts in the Medical Cannabis field with the intention of capitalising on the emerging global Medical Cannabis industry, founders Nativ Segev and Roby Zomer bring a combination of over 10 years in the Medical Cannabis and the BioTech industry. MGC Pharma was created to become a leading BioPharma company based on Medical Cannabis with operations spanning all aspects of the value chain, from cultivation, manufacturing and distribution of products in a global market.

Today, MGC Pharma has operations spanning Europe and Australia. It has cultivated and harvested crops in its growing facilities in the Czech Republic and Slovenia and is manufacturing active pharmaceutical ingredients (APIs) at its European GMP extraction facility. The Company has also developed a CBD cosmetics range that is available for purchase throughout Europe and online via the Company’s eShop www.mgcderma.com

MGC Botanic

The Botanic Division engages with multiple cultivation sites to meet increasing global demand, alongside research into breeding and genetics with leading institutions and academia. We will continue to harvest the product in Slovenia and Czech Republic, and use the raw material at our production facility, as well as provide the product globally.

Our research & development:

  • We’re excited to embark on a University of Ljubljana botanic research to develop new genetic strains.
    Refining and steadying MGC Pharma’s genetic bank to balance indications and treatment, and to guarantee our ability to produce flawless, high quality products all over the globe.  
    We’ve partnered with Academy of Science, Czech Republic, on numerous strain grows.
MGC Innovation

The Innovation Division is focused on our medical product pipeline and is our largest division. This division focuses on products that emerge from our supply line. These include neutraceuticals, which will be able to provide the additional needs and requirements that our body demands on a daily basis to improve our immune system, detoxify and enhance wellness.

Additionally, this includes our extracts, at various levels of purity, and with the ability to extract various phytocannabinoids and terpenes to the level of Active Pharmaceutical Ingredient.

The Innovation division is  focused on three specific areas of treatment:

  • Neurological disorders, which includes MGC Pharma’s proprietary formulations for Epilepsy
    Oncological care and treatment
    Autoimmune diseases, via taking advantage of the various anti-inflammatory benefits our products have on the body.
MGC Derma is our skincare and anti-aging line for day-to-day use. We are currently working on a new line of dermatological products called DermaPlus, which is already presenting impressive results from clinical studies. MGC Derma is a pioneering CBD cosmetic brand with distribution deals signed in various markets, presently in deliberations to engage in new markets.

MGC Derma produces CBD enhanced cosmetics, DermaPlus dermatological line and private label manufacturing.

Our research & development:

  • Derma Plus product range clinical tests finalized with the three products showing strong improvement in the skin conditions tests.
    Launch of product line in UK, Australia and USA planned for 2018.
 
Our three pioneering divisions allow MGC to be a key player in all significant levels of production in various global locations. It also allows MGC to progress with simultaneous high level research and development, clinical trials around the world and to embrace new emerging verticals in CBD markets.
 
MGC DERMA FEATURED ON CULT BEAUTY     https://www.cultbeauty.co.uk/mgc-derma

  •  
 

MGC Derma

MGC Derma is the brand leading the way in utilising this year’s ‘it’ skin care ingredient: cannabis. Before you get the wrong end of the stick… we’re talking about cannabidiol (CBD) a totally non-psychoactive compound derived from the cannabis plant, which shares part of the ‘fingerprint’ of our genetics, allowing the body to instantly recognise it – and utilise it accordingly. It is MGC Derma’s unique, meticulous extraction and purification process that keeps this ‘fingerprint’ intact; the brand uses only the highest quality cannabidiol in this range of pure yet potent serums, masks, toners and cream. Renowned for its healing, sebum-regulating and moisturising capabilities, CBD is particularly adept at addressing eczema, acne and other problematic skin conditions, as well as minimising signs of ageing, hydrating and nourishing.  

 
 
 

MGC Derma

MGC Derma is the brand leading the way in utilising this year’s ‘it’ skin care ingredient: cannabis. Before you get the wrong end of the stick… we’re talking about cannabidiol (CBD) a totally non-psychoactive compound derived from the cannabis plant, which shares part of the ‘fingerprint’ of our genetics, allowing the body to instantly recognise it – and utilise it accordingly. It is MGC Derma’s unique, meticulous extraction and purification process that keeps this ‘fingerprint’ intact; the brand uses only the highest quality cannabidiol in this range of pure yet potent serums, masks, toners and cream. Renowned for its healing, sebum-regulating and moisturising capabilities, CBD is particularly adept at addressing eczema, acne and other problematic skin conditions, as well as minimising signs of ageing, hydrating and nourishing.  

Cannabis Report
MGCLF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#865   I believe we’ll get the news today before GonzoinHD 09/24/18 01:11:05 PM
#864   I believe very good news coming tomorrow. The rushmann 09/24/18 12:25:34 PM
#863   I believe it's Canada-related GuiNoir 09/22/18 01:46:28 PM
#862   Financial Report for the year ended 30 June 2018 Salty_Dawg 09/22/18 11:07:32 AM
#861   Australian Phase II Clinical Trial into Dementia Salty_Dawg 09/22/18 11:01:40 AM
#860   Anyone have any information on the trading halt? Love3 09/22/18 10:37:50 AM
#859   Hope it's one of mine. Bigarm 09/20/18 09:36:04 PM
#858   who could it be? September 2018 Australian Securities Exchange Level Bigarm 09/20/18 09:34:43 PM
#857   Excessive negativity on the HC board. I can GuiNoir 09/18/18 11:08:59 AM
#856   Yeah, great post. Investors have to understand that rushmann 08/27/18 02:02:55 PM
#855   Welcome aboard jmk2454. Great post. Bigarm 08/24/18 01:36:55 PM
#854   A new blog post from Ron Lipsky regarding Jmk2454 08/24/18 06:26:36 AM
#853   Great news! CVSI's products are sold in GuiNoir 08/08/18 11:34:47 AM
#852   https://finfeed.com/small-caps/biotech/mgc-pharma-expands-presence-budding-uk-ca londonohoyos 08/08/18 06:50:52 AM
#851   Here is a news article I came across Bigarm 08/06/18 07:45:51 AM
#850   Well, for those that already saw the latest rushmann 07/30/18 02:28:38 PM
#848   Reillyblue's posts are excellent on HC. Also I GuiNoir 07/24/18 04:28:52 PM
#847   Reillyblue seems to be the most imformed and rushmann 07/22/18 09:48:49 PM
#846   Speaking of "in-the-know," who are the posters most GuiNoir 07/19/18 04:30:38 PM
#845   I agree with US investors not in the THEBEAV 07/13/18 10:48:13 AM
#844   Let me assure you Erin is still around rushmann 07/13/18 10:45:21 AM
#843   I'm going to write a letter to the THEBEAV 07/13/18 10:44:33 AM
#842   With the latest news no reason we shouldn't THEBEAV 07/13/18 10:42:52 AM
#841   I know Erin was working with management but THEBEAV 07/13/18 10:41:12 AM
#840   Yeah it's moving on no volume, couldn't sell THEBEAV 07/13/18 10:39:32 AM
#839   It's moving now, but there is still a rushmann 07/13/18 10:34:59 AM
#838   I can't understand why we are not moving THEBEAV 07/13/18 09:59:22 AM
#837   Super exciting!!! Go MGCLF Cooklamo 07/12/18 09:34:48 PM
#836   Huge news!! GMP Cert is finally ours! This rushmann 07/12/18 09:27:34 PM
#835   https://finfeed.com/small-caps/biotech/mgc-pharma-scores-gmp-licence-kicks-comme londonohoyos 07/12/18 08:47:53 PM
#834   https://stockhead.com.au/special-report/mgc-pharma-now-owns-one-of-the-most-adva londonohoyos 07/12/18 08:47:11 PM
#833   Trading halt may involve getting full GMP certification....which rushmann 07/11/18 09:09:08 AM
#832   Me too Dbabe4321 07/10/18 09:25:18 PM
#831   I would say yes. Bigarm 07/10/18 09:21:04 PM
#830   Good news? Dbabe4321 07/10/18 08:41:31 PM
#829   Trading halted in Australia. From the Australian exchange : The Bigarm 07/10/18 08:17:32 PM
#828   Hello all, the summer dog days are in rushmann 07/05/18 12:43:52 PM
#827   You called it BEAV, just picked up another GonzoinHD 06/28/18 01:43:57 PM
#826   Today is a day to buy with ask THEBEAV 06/28/18 11:56:38 AM
#825   FDA first time approval of a cannibis drug GuiNoir 06/25/18 05:07:09 PM
#824   Grabbed another 10k today. This will be over jk1283 06/22/18 05:48:21 PM
#823   How did the call go? zerowinner 06/20/18 06:10:30 PM
#822   I don't about anyone else, but I'm on rushmann 06/19/18 08:18:16 PM
#821   I wanted to update everyone trying to coordinate BostonErin 06/18/18 03:54:47 PM
#820   I think so. After my call BostonErin 06/15/18 11:23:22 AM
#819   Fantastic! Hopefully they will get things done and rushmann 06/14/18 09:33:47 PM
#818   Good news, I had my call I think BostonErin 06/14/18 03:09:57 PM
#817   I was very happy when I saw this. BostonErin 06/14/18 10:41:08 AM
#816   what is the correct # of outstanding shares??? bunky 06/13/18 06:48:47 PM
#815   Fantastic!! Knightsbridge is world-famous. There's an antique GuiNoir 06/12/18 09:35:38 AM
PostSubject